Annual Biosimilars Summit

This premier B2B event will enable the participants to explore strategies for overcoming scientific, regulatory and legal challenges in the development and commercialization of biosimilars through technical case studies and practical advice from leading biosimilar and regulatory players.

Key Practical Learning Points of the Summit:

  • The European Biosimilar landscape, what does the future hold: challenges & expectations
  • The commercial game and how to play commercial strategy to increase market uptake
  • Forecasting biosimilar product portfolios and effectively planning and realigning business strategies for future changes
  • Facilitating the acceptance and increasing the uptake of biosimilars
  • The experience exchange: developing and introducing biosimilars to new markets
  • Overview of Global R&D and regulatory landscape

Who Should Attend: 

  • Biosimilars / Biologics / Biotechnology / Biogenerics
  • Biopharmaceuticals / Biotherapeutics
  • Portfolio Development
  • Market Strategy
  • Regulatory Affairs
  • R&D
  • Preclinical and Clinical Development
  • Regulatory Compliance
  • Regulatory Strategy
  • New Product Development
  • Pricing and Reimbursement
  • Clinical Immunology
  • Quality Affairs / Quality Control
  • Principal Scientist
  • Chief Scientific Officer
  • Medical Director/Leader
  • Business Development
  • Commercial Affairs
  • Marketing & Sales
  • Business Development